Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 40

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 40
---
 actual offering amount, placement agent
fees and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth above. We may
sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors
in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to fund for our operations
as described in the “Use of Proceeds” section herein. Thus, we may not raise the amount of capital we believe is required
for our operations in the short-term and even if we raise the maximum offering amount in this public offering, we will need to raise additional
funds in the future, which may not be available or available on terms acceptable to us. For more on the risks related to our funding requirements,
see “Risk Factors—Risks Related to Our Business—Our financial statements have been prepared on a going-concern basis and our continued operations are in doubt.”

The Warrants are speculative in nature.

The Series A-1 Warrants, Series A-2 Warrants and Pre-Funded Warrants
offered in this offering do not confer any rights of common stock ownership on their holders, such as voting rights or the right to receive
dividends, but rather merely represent the right to acquire shares of our common stock at a fixed price for a limited period of time.
Specifically, effective on the Initial Exercise Date, holders of the Series A-1 Warrants and Series A-2 Warrants may exercise their right
to acquire the common stock and pay an exercise price of $1.90 per share, prior to the fifth year anniversary and 18 month anniversary,
respectively, from the Initial Exercise Date, after which date any unexercised Warrants will expire and have no further value. Commencing
on the date of issuance, holders of the Pre-Funded Warrants may exercise their right to acquire shares of common stock and pay an exercise
price of $0.001 per share. The Pre-Funded Warrants have no expiration date.

Holders of the Warrants and the Pre-Funded Warrants will have no rights as a common stockholder until they acquire our common stock.

Until holders of the Warrants and the Pre-Funded
Warrants acquire shares of our common stock upon exercise of those warrants, the holders will have no rights with respect to the common
stock issuable upon exercise thereof. Upon exercise of those warrants, the holder will